Having demonstrated that PRMT5 expression is upregulated, as well as positively correlated with KRAS expression, in CRC patient datasets, we next sought to determine whether PRMT5 is further overexpressed in KRAS mutant CRC cells when compared to KRAS WT CRC cells. Here, KRAS is linked to colorectal carcinoma.